Godaddy Inc vs Heron Therapeutics Inc — how do they compare? Godaddy Inc trades at $92.36 (market cap $11.49B), while Heron Therapeutics Inc trades at $0.34 (market cap $61.47M). The key difference: Godaddy Inc is far larger — about 186.9× Heron Therapeutics Inc's market cap, and Godaddy Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| GDDY | HRTX | |
|---|---|---|
Market Cap | $11.49B | $61.47M |
Sector | Technology | Health |
52-Week High | $148.88 | $1.49 |
52-Week Low | $75.07 | $0.32 |
Enterprise Value | $14.18B | $168.21M |
Signals from Pluang's Aura AI — not financial advice
GoDaddy (GDDY) trades at $90.78, down 0.78% on the day, with a bearish technical signal and mixed sentiment due to ongoing securities investigations. Fundamentally, the company shows strength with consistent earnings beats, revenue growth to $4.95B in 2025, and robust profitability margins. The stock trades at a P/E of 13.48, below the sector average, while analyst consensus targets $112.13, implying significant upside.
The outlook is cautiously optimistic given solid fundamentals and analyst support, but near-term volatility is likely from legal overhangs and technical resistance. Key risks include potential litigation outcomes and competitive pressures in web services. Upside hinges on continued execution and clearing regulatory concerns.
HRTX trades at $0.3507, up 6.21% in the last 24 hours, but technical indicators signal a bearish trend overall. The company reported Q2 2026 revenue of $37.7 million, missing estimates, with a net loss per share of $0.03. Despite a high gross profit margin of 70.07%, negative net income and cash flow from operations highlight financial strain. Analyst consensus remains strongly bullish with 94.74% buy ratings, but recent news includes a Zacks Strong Sell designation on July 15, 2026.
The outlook is mixed: strong analyst support contrasts with weak earnings and bearish technicals. Investment opportunity lies in potential turnaround if revenue growth accelerates, but risks include persistent losses, competitive pressures, and reliance on financing activities. The stock faces significant downside if operational performance does not improve.
Trailing returns across standard periods
Latest headlines on both assets
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →